METHYL-(2''R/S)-5,6-DIDEOXY-6-[1-(THIOLAN-2-YL)-CYTOSIN-5-YL]-BETA-D-RIBO-HEX-5-YNOFURANOSIDE
Compound with spectra: 1 NMR
![METHYL-(2''R/S)-5,6-DIDEOXY-6-[1-(THIOLAN-2-YL)-CYTOSIN-5-YL]-BETA-D-RIBO-HEX-5-YNOFURANOSIDE](/api/compound/BDiKEucdO9N.png?ph=true&h=300&w=458 "METHYL-(2''R/S)-5,6-DIDEOXY-6-[1-(THIOLAN-2-YL)-CYTOSIN-5-YL]-BETA-D-RIBO-HEX-5-YNOFURANOSIDE")
| SpectraBase Compound ID | BDiKEucdO9N |
|---|---|
| InChI | InChI=1S/2C15H19N3O5S/c2*1-22-14-12(20)11(19)9(23-14)5-4-8-7-18(10-3-2-6-24-10)15(21)17-13(8)16/h2*7,9-12,14,19-20H,2-3,6H2,1H3,(H2,16,17,21)/t9-,10+,11-,12-,14-;9-,10-,11-,12-,14-/m00/s1 |
| InChIKey | JBVPZVMPKUVAAV-KGUMYQADSA-N |
| Mol Weight | 706.79 g/mol |
| Molecular Formula | C30H38N6O10S2 |
| Exact Mass | 706.209084 g/mol |
| Enantiomer InChIKey | JBVPZVMPKUVAAV-NDHQJXLESA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3:CD3OD=4:1 |
METHYL-(2''R/S)-5,6-DIDEOXY-6-[1-(THIOLAN-2-YL)-CYTOSIN-5-YL]-BETA-D-RIBO-HEXAFURANOSIDE
5-BENZYLOXYMETHYL-1-(2',3'-DIDEOXY-5-O-(4-METHYLBENZOYL)-CYTIDINE
1-(2',3'-DIDEOXY-5-O-(4-METHYLBENZOYL)-ALPHA-D-GLYCERO-PENTOFURANOSYL)-5-PENTYLOXYMETHYLCYTOSINE
2',3'-DIDEOXY-5-O-(4-METHYLBENZOYL)-5-PENTYLOXYMETHYLCYTIDINE
5-Phenyl-2'-deoxycytidine
5-CARBAMOYLMETHYL-2'-DEOXYCYTIDINE
METHYL-O-beta-D-GALAKTOPYRANOSYL-(1->4)-O-beta-D-GLUCOPYRANOYL-(1->4)-O-3-O-beta-D-GALAKTOPYRANOSYL-(1->4)
MONO-(6-DEOXY-6-THIODECAMETHYLENETHIOL)-BETA-CYCLODEXTRIN;CD(10)
6-O-Butyryl.beta.-D-maltotriose
3'-O-(6-AMINOHEXYL)-2'-DEOXY-CYTIDINE-5'-YL-DIHYDROGEN-PHOSPHATE
| Title | Journal or Book | Year |
|---|---|---|
| 5-Substituted (1-Thiolan-2-yl)cytosines as Inhibitors ofA. aeolicusandE. coliIspE Kinases: Very Different Affinities to Similar Substrate-Binding Sites | European Journal of Organic Chemistry | 2013 |